Moberg Pharma AB (publ) (MBGPF)
OTCMKTS
· Delayed Price · Currency is USD
0.9375
-0.0395 (-4.04%)
Jun 3, 2025, 9:30 AM EDT
Moberg Pharma AB Revenue
Moberg Pharma AB had revenue of 3.87M SEK in the quarter ending March 31, 2025, with 371.83% growth. This brings the company's revenue in the last twelve months to 12.86M, up 1,468.29% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.
Revenue (ttm)
12.86M SEK
Revenue Growth
+1,468.29%
P/S Ratio
34.40
Revenue / Employee
1.29M SEK
Employees
10
Market Cap
44.07M USD
Revenue Chart
* This company reports financials in SEK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Federal National Mortgage Association | 30.44B |
| Federal Home Loan Mortgage | 23.43B |
| Jingbo Technology | 1.96M |
| Alpine Auto Brokers | 129.78K |
| First National of Nebraska | 1.89B |
| Mechanics Bank | 381.61M |
| Wilson Bank Holding Company | 189.72M |
| Endo Inc. | 1.73B |
Moberg Pharma AB News
- 6 months ago - Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU - PRNewsWire
- 9 months ago - Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients - PRNewsWire
- 1 year ago - Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98% - PRNewsWire